Search results
In this exclusive interview, we chat with ViaDerma’s founder & CEO, Dr. Christopher Otiko, about the origins of the company, the groundbreaking technology behind their products, and their plans for global expansion as they continue to lead the charge in combating some of the world’s most dangerous pathogens.
- Article Summary
- Predestined Journey
- His Entrepreneurial Spirit
- Focus on His Philanthropy
Dr Christopher Otiko is a Nigerian-American Podiatric specialist and entrepreneurHe was concerned with diabetic patients having to undergo amputations because of untreated diabetic ulcersThis led to his invention of a potent drug for the treatment of diabetic ulcersDr Otiko’s journey in the medical field seemed almost predestined. Even as a mere sprout of a human being, at the tender age of five, he requested a doctor’s kit for his birthday. Only future medical prodigies do this. Delving into his early background Dr Christopher Otiko hails from Nigerian but embarked on an adventure that took him across the gl...
After eight long years of trials, errors, and unwavering determination, the day finally came. Vitastem, the FDA-registered drug, made its grand entrance into the United States market in 2008, marking a turning point in the world of diabetes treatment, With this accomplishment, the doctor made his mark in the pharmaceutical industry. Vitastem is a t...
Driven by a deep sense of purpose, Dr Otiko was not content with keeping his knowledge and skills confined to the United States. Despite leaving Nigeria behind over three decades ago, he felt a burning desire to give back to his countrymen. With this in mind, he embarked on a mission to register Vitastem with the National Agency for Food and Drug A...
Meet Doctor Chris. Dr. Christopher Otiko received a Master’s of Science Degree in Biochemistry from Oklahoma State University in 1993 and a Doctorate from the California College of Podiatric Medicine, San Francisco in 1997.
Don't forget to subscribe: https://bit.ly/2Hb8hjxWatch more interesting videos: https://bit.ly/34ogCawFollow Channels Television On: Facebook: https://www.f...
- 25 min
- 4.6K
- Channels Television
A United States of America (USA) based Nigerian Medical Doctor, Christopher Ayo Otiko has discovered a drug called TETRACYTE for the treatment of diabetic ulcer.
Sep 29, 2023 · We also share several insights from Dr. Christopher Otiko, the founder of ViaDerma, as he discusses the company’s mission, the effectiveness of Vitastem Ultra against antibiotic-resistant bacteria, such as staph infection, MRSA (flesh-eating bacteria), and the vast markets they aim to serve globally.
Apr 11, 2023 · Here are a few questions with Dr. Christopher Otiko, the founder & CEO of ViaDerma. What made you decide to start ViaDerma? I really wanted to start a company that produces medication that could save a lot of lives.
